Similarly, celastrol could inhibit intestinal FXR and increase the excretion of bile acids, which decreases the levels of hepatic TCDCA and prevents TAA- and MCD diet-induced hepatic fibrosis. The gene discussed is NR1H4; the disease is Hepatic fibrosis.